Profusa, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Profusa, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 21.1 times its market value (net debt). Lower than almost all Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-2.3×Operating cash was negative last year, while some debt falls due within a year.
Higher than 63% of Healthcare companies in United States.
Cash Cushion Ratio
21.1× debtDebt, after subtracting cash, is 21.1 times its market value (net debt).
Lower than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Profusa, Inc. owes $27.0 for every $1 it owns. Profusa, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
0.0Investors pay $0.0 for every $1 of Profusa, Inc.'s yearly profit, lower than almost all Healthcare companies in United States.
P/B ratio
-0.02Profusa, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$1 MThe total market value of all of Profusa, Inc.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeProfusa, Inc.'s net worth is negative ($27 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
27.0×Profusa, Inc. owes $27.0 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Dividend yield
NoneProfusa, Inc. does not currently pay a dividend.
Profit growth
LossProfusa, Inc. made a loss in each of the last two years.
Interest cover
Not coveredProfusa, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtProfusa, Inc. had $13 M more debt than cash (net debt) at Dec 2025.
Questions
What is Profusa, Inc.'s P/E ratio?
Investors pay $0.0 for every $1 of Profusa, Inc.'s yearly profit, lower than almost all Healthcare companies in United States.
How much does Profusa, Inc. owe compared with what it owns?
Profusa, Inc. owes $27.0 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Does Profusa, Inc. pay a dividend?
No. Profusa, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.